LUNGevity Foundation
Michael has over 25 years of diverse healthcare industry experience with an intense focus on biotechnology and oncology. Currently he is the CEO of Guidemark Health, a diversified healthcare communications agency with a focus on oncology and rare diseases.
He spent 17 years within the Ogilvy Healthcare organization, where he worked across all aspects of the oncology marketplace, creating long-standing partnerships with many biopharma companies and academic centers on the cutting edge of cancer research. He is a critical thinker, problem solver, and someone who thrives in new emerging approaches to solving the world’s biggest healthcare challenges.
Named to the PharmaVOICE 100 Most Inspiring Healthcare Leaders in 2016 for his leadership and innovation in cancer and rare diseases, Michael is a recognized leader and cancer advocate. He currently serves as the President of the Board of Trustees of CancerCare, a partner of LUNGevity. Additionally, since 2012 he has served on the board of the NCCN Foundation, an organization that represents 28 of the world’s leading cancer centers.
Michael holds a BA degree in psychology, which is where he became a hospice counselor, focused specifically on dealing with people suffering the end stage of a cancer diagnosis. He also holds an MBA in corporate finance.
This person is not in the org chart
This person is not in any offices
LUNGevity Foundation
2 followers
LUNGevity Foundation is the nation's leading lung cancer organization focused on improving outcomes for people with lung cancer through research, policy initiatives, education, support, and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live longer and better lives.